Personen

TOP 5 Publikationen:

1. Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany.Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print].
2. Gründer G, Brand M, Mertens L, Jungaberle H, Kärtner L, Scharf DJ, Spangemacher M, Wolff M. Treatment with psychedelics is psychotherapy: beyond reductionism.Lancet Psychiatry. 2024 11(3):231-236. Epub 2023 Dec 12.
3. Meinhardt M, Güngör C, Skorodumov I, Mertens L, Spanagel R. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.Neuropsychopharmacology. 2020 45(8):1316-1322. Epub 2020 May 5.
4. Spangemacher M, Mertens L, Färber LV, Jungaberle A, Jungaberle H, Gründer G. Psilocybin as a Disease-Modifying Drug—a Salutogenic Approach in Psychiatry.Dtsch Arztebl Int. 2024 121(26):868-874. Epub 2024 Dec 27.
5. Wolff M, Evens R, Mertens LJ, Schmidt C, Beck J, Rutrecht H, Cherniak AD, Gründer G, Jungaberle H. Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).J Psychopharmacol. 2024 38(5):432-457. Epub 2024 May 14.